Hear from the DOJ, SEC & FBI at the Upcoming Life Sciences Strategies for Anti-Corruption & FCPA Compliance Conference
Online, June 9, 2011 (Newswire.com) - marcus evans, a business to business conference provider, will host the Life Sciences Strategies for Anti-Corruption and FCPA Compliance Conference, June 22-24, 2011 at the Sheraton Premiere at Tyson's Corner in Washington, DC. Attendees will hear from 18 industry leaders and government officials as they share best practices and strategies in overcoming FCPA risk.
Pharmaceutical and medical device companies operating overseas are particularly vulnerable to FCPA violations because of the nature of public health systems in many foreign countries where health care systems are owned and operated by the government. Given the fact that employees are in constant contact with the health care providers at different touch points within the organization, there is a need to ensure all interactions are monitored and effective policies are in place to curb any potential violations.
Key speakers at the event include:
William J. Stuckwisch, Assistant Chief Fraud Section, Criminal Division at the U.S. Department of Justice Charles E. Cain, Assistant Director, Division of Enforcement at the United State Securities and Exchange Commission
Gary Johnson, Supervisory Special Agency at the International Corruption Unit, FBIHQ
Jeffrey L. Antoon, Director-Corporate, Internal Audit at Johnson & Johnson
Alexandra Peters, Director, Global Anti-Corruption Program at Medtronic, Inc.
Jeffery D. Williams, Vice President and Assistant General Counsel, Compliance Division at Pfizer Inc.
With a one-track focus, the Life Sciences Strategies for Anti-Corruption & FCPA Compliance Conference is a highly intensive, content-driven event that includes case studies, presentations and panel discussions over two full days. This conference targets industry leaders from the pharmaceutical, medical device and biotechnology and clinical research organizations in order to provide an intimate atmosphere for both the delegates and speakers.
marcus evans invites senior level professionals and In-House Counsel that work within FCPA, Anti-Corruption and Compliance to join in this cutting-edge, peer-to-peer conference that examines best practices in the industry. In addition to two days of conference sessions, attendees will have extensive networking opportunities with their peers.
CONFERENCE AGENDA
· Two Pre-Conference Workshops on June 22, 2011:
o Workshop A: "Mitigating the Risk of FCPA Violations Through the Careful and Continual Monitoring of Gift and Entertainment Requests"
o Workshop B: "Executing Timely and Cost-Efficient Internal Investigations to Determine the Legitimacy of an FCPA Violation Claim"
· Day One, June 23, 2011:
o Assessing the Latest Enforcement Trends and Regulatory Updates
o Developing Effective Internal Controls for Compliance
o Conquering FCPA and Corruption Risk Areas Through the Entire Supply Chain
· Day Two, June 24, 2011:
o Global Regulatory Perspectives on the Fight to Combat Corruption
o Ensuring Robust Processes are in Place Across All Potential Corruption Practices
o Handling Internal Investigations & Building an Ethical Business
For more information on this conference or to get a complete list of speakers, sessions or past attendees, visit http://www.marcusevansch.com/LifeSciencesFCPA or contact Michele Westergaard at [email protected] or 312-540-3000 ext. 6625.
About marcus evans
marcus evans conferences annually produce over 2,000 high quality events designed to provide key strategic business information, best practice and networking opportunities for senior industry decision-makers. Our global reach is utilized to attract over 30,000 speakers annually, ensuring niche focused subject matter presented directly by practitioners and a diversity of information to assist our clients in adopting best practice in all business disciplines.
Share:
Tags: bribery, Compliance, corruption, FCPA